Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_assertion type Assertion NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_head.
- NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_assertion description "[Hence, the view is emerging that pharmacological targeting of distinct PI3K isoforms could be successful in treating disorders such as myocardial infarction and heart failure, besides inflammatory diseases and cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_provenance.
- NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_assertion evidence source_evidence_literature NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_provenance.
- NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_assertion SIO_000772 22403077 NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_provenance.
- NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_assertion wasDerivedFrom befree-20150227 NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_provenance.
- NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_assertion wasGeneratedBy ECO_0000203 NP623706.RAk1UKoqskH59devJtp5cPgEcr9GVsRFA5F7t-gild7vE130_provenance.